Vonetta M Dotson1, Susan M Resnick, Alan B Zonderman. 1. Laboratory of Personality and Cognition, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA. dotsonv@mail.nih.gov
Abstract
OBJECTIVES: The impact of depressive symptoms on cognitive decline in older adults remains unclear due to inconsistent findings in the literature. It is also unclear whether effects of depressive symptoms on cognitive decline vary with age. This study investigated the effect of concurrent, baseline, and average depressive symptoms on cognitive functioning and decline, and examined the interactive effect of age and depressive symptoms on cognition. DESIGN: Prospective observational design with examination of cognitive performance and depressive symptoms at 1- to 2-year intervals for up to 26 years. SETTING: Baltimore Longitudinal Study of Aging, National Institute on Aging. PARTICIPANTS: One thousand five hundred eighty-six dementia-free adults 50 years of age and older. MEASUREMENTS: Scores over time on the Center for Epidemiologic Studies Depression Scale and measures of learning and memory, attention and executive functions, verbal and language abilities, visuospatial functioning, and general cognitive status. RESULTS: Increased depressive symptoms were associated with poor cognitive functioning and cognitive decline in multiple domains. Concurrent, baseline, and average depressive symptoms had differential associations with cognition. Average depressive symptoms, a measure of chronic symptoms, seemed to show the most widespread effects on cognitive abilities. Effects of depressive symptoms on some frontal functions were greater with advancing age. CONCLUSION: Depressive symptoms are associated with poor cognitive functioning and cognitive decline, particularly with advancing age. The widespread impact of average depressive symptoms on cognition suggests that clinicians should consider the chronicity of depressive symptoms when evaluating cognitive functioning in older adults.
OBJECTIVES: The impact of depressive symptoms on cognitive decline in older adults remains unclear due to inconsistent findings in the literature. It is also unclear whether effects of depressive symptoms on cognitive decline vary with age. This study investigated the effect of concurrent, baseline, and average depressive symptoms on cognitive functioning and decline, and examined the interactive effect of age and depressive symptoms on cognition. DESIGN: Prospective observational design with examination of cognitive performance and depressive symptoms at 1- to 2-year intervals for up to 26 years. SETTING: Baltimore Longitudinal Study of Aging, National Institute on Aging. PARTICIPANTS: One thousand five hundred eighty-six dementia-free adults 50 years of age and older. MEASUREMENTS: Scores over time on the Center for Epidemiologic Studies Depression Scale and measures of learning and memory, attention and executive functions, verbal and language abilities, visuospatial functioning, and general cognitive status. RESULTS: Increased depressive symptoms were associated with poor cognitive functioning and cognitive decline in multiple domains. Concurrent, baseline, and average depressive symptoms had differential associations with cognition. Average depressive symptoms, a measure of chronic symptoms, seemed to show the most widespread effects on cognitive abilities. Effects of depressive symptoms on some frontal functions were greater with advancing age. CONCLUSION:Depressive symptoms are associated with poor cognitive functioning and cognitive decline, particularly with advancing age. The widespread impact of average depressive symptoms on cognition suggests that clinicians should consider the chronicity of depressive symptoms when evaluating cognitive functioning in older adults.
Authors: M I Geerlings; R A Schoevers; A T Beekman; C Jonker; D J Deeg; B Schmand; H J Adèr; L M Bouter; W Van Tilburg Journal: Br J Psychiatry Date: 2000-06 Impact factor: 9.319
Authors: Natalie Sachs-Ericsson; Andrea B Burns; Kathryn H Gordon; Lisa A Eckel; Steven A Wonderlich; Ross D Crosby; Dan G Blazer Journal: Am J Geriatr Psychiatry Date: 2007-09 Impact factor: 4.105
Authors: R S Wilson; C F Mendes De Leon; D A Bennett; J L Bienias; D A Evans Journal: J Neurol Neurosurg Psychiatry Date: 2004-01 Impact factor: 10.154
Authors: Stephen D Anton; Adam J Woods; Tetso Ashizawa; Diana Barb; Thomas W Buford; Christy S Carter; David J Clark; Ronald A Cohen; Duane B Corbett; Yenisel Cruz-Almeida; Vonetta Dotson; Natalie Ebner; Philip A Efron; Roger B Fillingim; Thomas C Foster; David M Gundermann; Anna-Maria Joseph; Christy Karabetian; Christiaan Leeuwenburgh; Todd M Manini; Michael Marsiske; Robert T Mankowski; Heather L Mutchie; Michael G Perri; Sanjay Ranka; Parisa Rashidi; Bhanuprasad Sandesara; Philip J Scarpace; Kimberly T Sibille; Laurence M Solberg; Shinichi Someya; Connie Uphold; Stephanie Wohlgemuth; Samuel Shangwu Wu; Marco Pahor Journal: Ageing Res Rev Date: 2015-10-14 Impact factor: 10.895
Authors: Suzanne C Danhauer; Claudine Legault; Hanna Bandos; Kelley Kidwell; Joseph Costantino; Leslie Vaughan; Nancy E Avis; Steve Rapp; Laura H Coker; Michelle Naughton; Cecile Naylor; Antonio Terracciano; Sally Shumaker Journal: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn Date: 2012-12-14
Authors: Jamie L Hamilton; Adam M Brickman; Rosalyn Lang; Goldie S Byrd; Jonathan L Haines; Margaret A Pericak-Vance; Jennifer J Manly Journal: J Int Neuropsychol Soc Date: 2014-05-19 Impact factor: 2.892
Authors: Joseph S Goveas; Mark A Espeland; Patricia E Hogan; Hilary A Tindle; Regina A Shih; Jane M Kotchen; Jennifer G Robinson; Deborah E Barnes; Susan M Resnick Journal: J Geriatr Psychiatry Neurol Date: 2014-02-28 Impact factor: 2.680
Authors: Olga M Herren; Silas E Burris; Shellie-Anne Levy; Keri Kirk; Kanesha S Banks; Victor L Jones; Breanna Beard; Denee T Mwendwa; Clive O Callender; Alfonso L Campbell Journal: Ethn Dis Date: 2019-04-18 Impact factor: 1.847
Authors: M Jokela; A Singh-Manoux; J E Ferrie; D Gimeno; T N Akbaraly; M J Shipley; J Head; M Elovainio; M G Marmot; M Kivimäki Journal: Psychol Med Date: 2009-09-01 Impact factor: 7.723